Process View
The network for 'lymphocyte apoptotic process' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
Any apoptotic process in a lymphocyte, a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Igh | immunoglobulin heavy chain complex | 0.991 | |
Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 0.989 | |
Pten | phosphatase and tensin homolog | 0.989 | |
Trp53 | transformation related protein 53 | 0.986 | |
Nfkb2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 | 0.961 | |
Hif1a | hypoxia inducible factor 1, alpha subunit | 0.936 | |
Lyn | Yamaguchi sarcoma viral (v-yes-1) oncogene homolog | 0.868 | |
Fas | Fas (TNF receptor superfamily member 6) | 0.852 | |
Cd19 | CD19 antigen | 0.851 | |
Tnfaip3 | tumor necrosis factor, alpha-induced protein 3 | 0.756 | |
Bcl2 | B-cell leukemia/lymphoma 2 | 0.753 | |
Casp4 | caspase 4, apoptosis-related cysteine peptidase | 0.752 | |
Cd40 | CD40 antigen | 0.739 | |
Lyz2 | lysozyme 2 | 0.649 | |
Ripk1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.601 | |
Bax | BCL2-associated X protein | 0.562 | |
Lepr | leptin receptor | 0.556 | |
Ace | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 0.550 | |
Traf2 | TNF receptor-associated factor 2 | 0.548 | |
Csf1 | colony stimulating factor 1 (macrophage) | 0.547 | |
Myd88 | myeloid differentiation primary response gene 88 | 0.517 | |
Ctnnb1 | catenin (cadherin associated protein), beta 1 | 0.517 | |
Kit | kit oncogene | 0.515 | |
Il1r1 | interleukin 1 receptor, type I | 0.498 | |
Pik3r1 | phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) | 0.473 | |
Pax3 | paired box gene 3 | 0.469 | |
Traf6 | TNF receptor-associated factor 6 | 0.466 | |
Tnf | tumor necrosis factor | 0.463 | |
Tlr4 | toll-like receptor 4 | 0.457 | |
Trp73 | transformation related protein 73 | 0.436 | |
Fgfr2 | fibroblast growth factor receptor 2 | 0.420 | |
Egfr | epidermal growth factor receptor | 0.386 | |
Cd44 | CD44 antigen | 0.375 | |
Insr | insulin receptor | 0.361 | |
Fgf10 | fibroblast growth factor 10 | 0.335 | |
Rara | retinoic acid receptor, alpha | 0.332 | |
Socs1 | suppressor of cytokine signaling 1 | 0.330 | |
Il10 | interleukin 10 | 0.306 | |
Pnp2 | purine-nucleoside phosphorylase 2 | 0.295 | |
Casp8 | caspase 8 | 0.292 | |
Gdnf | glial cell line derived neurotrophic factor | 0.291 | |
Pax2 | paired box gene 2 | 0.290 | |
Wnt6 | wingless-related MMTV integration site 6 | 0.290 | |
Pik3cd | phosphatidylinositol 3-kinase catalytic delta polypeptide | 0.281 | |
Rxra | retinoid X receptor alpha | 0.281 | |
Dffb | DNA fragmentation factor, beta subunit | 0.280 | |
Wnt3a | wingless-related MMTV integration site 3A | 0.277 | |
Adam12 | a disintegrin and metallopeptidase domain 12 (meltrin alpha) | 0.273 | |
Foxn1 | forkhead box N1 | 0.267 | |
Lck | lymphocyte protein tyrosine kinase | 0.266 | |
Lat | linker for activation of T cells | 0.260 | |
Wnt4 | wingless-related MMTV integration site 4 | 0.258 | |
Map3k8 | mitogen-activated protein kinase kinase kinase 8 | 0.257 | |
Ptgs2 | prostaglandin-endoperoxide synthase 2 | 0.252 | |
Gli3 | GLI-Kruppel family member GLI3 | 0.250 | |
Spib | Spi-B transcription factor (Spi-1/PU.1 related) | 0.237 | |
Rarg | retinoic acid receptor, gamma | 0.235 | |
Nr3c1 | nuclear receptor subfamily 3, group C, member 1 | 0.222 | |
Bmp4 | bone morphogenetic protein 4 | 0.218 | |
Adam17 | a disintegrin and metallopeptidase domain 17 | 0.216 | |
Plcg2 | phospholipase C, gamma 2 | 0.212 | |
Icos | inducible T-cell co-stimulator | 0.210 | |
Nos3 | nitric oxide synthase 3, endothelial cell | 0.209 | |
Dok1 | docking protein 1 | 0.200 | |
Grb2 | growth factor receptor bound protein 2 | 0.197 | |
Ptch2 | patched homolog 2 | 0.190 | |
Stat3 | signal transducer and activator of transcription 3 | 0.189 | |
Apoe | apolipoprotein E | 0.186 | |
Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.183 | |
Foxf1a | forkhead box F1a | 0.182 | |
Meox2 | mesenchyme homeobox 2 | 0.181 | |
Lhx1 | LIM homeobox protein 1 | 0.178 | |
Tnfrsf13c | tumor necrosis factor receptor superfamily, member 13c | 0.178 | |
Wt1 | Wilms tumor 1 homolog | 0.176 | |
Cd5 | CD5 antigen | 0.172 | |
Dkk1 | dickkopf homolog 1 (Xenopus laevis) | 0.165 | |
Adam19 | a disintegrin and metallopeptidase domain 19 (meltrin beta) | 0.163 | |
Tnfrsf1b | tumor necrosis factor receptor superfamily, member 1b | 0.159 | |
Cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 0.155 | |
Tnfrsf11a | tumor necrosis factor receptor superfamily, member 11a | 0.152 | |
Anxa4 | annexin A4 | 0.151 | |
Pax8 | paired box gene 8 | 0.148 | |
Bcl6 | B-cell leukemia/lymphoma 6 | 0.146 | |
Efs | embryonal Fyn-associated substrate | 0.142 | |
Socs3 | suppressor of cytokine signaling 3 | 0.142 | |
Ctsw | cathepsin W | 0.138 | |
Lgr4 | leucine-rich repeat-containing G protein-coupled receptor 4 | 0.138 | |
Pou3f2 | POU domain, class 3, transcription factor 2 | 0.137 | |
Icam1 | intercellular adhesion molecule 1 | 0.135 | |
Bcl2l1 | BCL2-like 1 | 0.134 | |
Irf4 | interferon regulatory factor 4 | 0.131 | |
Map3k7 | mitogen-activated protein kinase kinase kinase 7 | 0.130 | |
Plaur | plasminogen activator, urokinase receptor | 0.129 | |
Il2rb | interleukin 2 receptor, beta chain | 0.128 | |
Ret | ret proto-oncogene | 0.126 | |
Fgfr1 | fibroblast growth factor receptor 1 | 0.123 | |
Sh2d2a | SH2 domain protein 2A | 0.120 | |
Pik3ca | phosphatidylinositol 3-kinase, catalytic, alpha polypeptide | 0.119 | |
Egln1 | EGL nine homolog 1 (C. elegans) | 0.119 | |
Wnt7b | wingless-related MMTV integration site 7B | 0.118 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 1.000 | |
TRAF1 | TNF receptor-associated factor 1 | 0.995 | |
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.992 | |
BCL2 | B-cell CLL/lymphoma 2 | 0.986 | |
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.984 | |
BAX | BCL2-associated X protein | 0.935 | |
BCL2L1 | BCL2-like 1 | 0.926 | |
FAS | Fas (TNF receptor superfamily, member 6) | 0.925 | |
FADD | Fas (TNFRSF6)-associated via death domain | 0.917 | |
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.916 | |
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.906 | |
BIRC3 | baculoviral IAP repeat containing 3 | 0.854 | |
BID | BH3 interacting domain death agonist | 0.839 | |
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.823 | |
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.801 | |
IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.766 | |
CCR5 | chemokine (C-C motif) receptor 5 | 0.742 | |
CD2 | CD2 molecule | 0.685 | |
ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.665 | |
BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.646 | |
TRAF2 | TNF receptor-associated factor 2 | 0.598 | |
CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.546 | |
IL10RA | interleukin 10 receptor, alpha | 0.523 | |
CCL4 | chemokine (C-C motif) ligand 4 | 0.468 | |
TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.466 | |
BMPR1A | bone morphogenetic protein receptor, type IA | 0.450 | |
FASLG | Fas ligand (TNF superfamily, member 6) | 0.437 | |
CCR7 | chemokine (C-C motif) receptor 7 | 0.415 | |
INSR | insulin receptor | 0.408 | |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.390 | |
LCK | lymphocyte-specific protein tyrosine kinase | 0.337 | |
TP53 | tumor protein p53 | 0.335 | |
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.333 | |
TRADD | TNFRSF1A-associated via death domain | 0.251 | |
DFFB | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) | 0.224 | |
CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.198 | |
BAD | BCL2-associated agonist of cell death | 0.196 | |
FYN | FYN oncogene related to SRC, FGR, YES | 0.191 | |
NOXA1 | NADPH oxidase activator 1 | 0.190 | |
IL22RA1 | interleukin 22 receptor, alpha 1 | 0.181 | |
TRAF3 | TNF receptor-associated factor 3 | 0.177 | |
SQSTM1 | sequestosome 1 | 0.175 | |
MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.170 | |
S100A6 | S100 calcium binding protein A6 | 0.167 | |
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.167 | |
CCL5 | chemokine (C-C motif) ligand 5 | 0.158 | |
CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.156 | |
CCL13 | chemokine (C-C motif) ligand 13 | 0.150 | |
TGIF1 | TGFB-induced factor homeobox 1 | 0.139 | |
CARD11 | caspase recruitment domain family, member 11 | 0.126 | |
BAK1 | BCL2-antagonist/killer 1 | 0.124 | |
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.123 | |
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.117 | |
CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.113 | |
MSN | moesin | 0.108 | |
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.104 | |
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.102 | |
MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.091 | |
CCL8 | chemokine (C-C motif) ligand 8 | 0.090 | |
PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.088 | |
S100A4 | S100 calcium binding protein A4 | 0.087 | |
IL2RB | interleukin 2 receptor, beta | 0.085 | |
CD28 | CD28 molecule | 0.082 | |
TNF | tumor necrosis factor | 0.081 | |
CD80 | CD80 molecule | 0.080 | |
CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.078 | |
VIM | vimentin | 0.072 | |
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.072 | |
BIRC2 | baculoviral IAP repeat containing 2 | 0.070 | |
PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.068 | |
IL2RG | interleukin 2 receptor, gamma | 0.067 | |
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.066 | |
IL32 | interleukin 32 | 0.066 | |
INCENP | inner centromere protein antigens 135/155kDa | 0.066 | |
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.065 | |
PXMP2 | peroxisomal membrane protein 2, 22kDa | 0.064 | |
IL10 | interleukin 10 | 0.062 | |
CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.062 | |
CD48 | CD48 molecule | 0.059 | |
PRKCZ | protein kinase C, zeta | 0.058 | |
PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.057 | |
PTPRC | protein tyrosine phosphatase, receptor type, C | 0.055 | |
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.055 | |
IL2RA | interleukin 2 receptor, alpha | 0.054 | |
TP53BP2 | tumor protein p53 binding protein, 2 | 0.054 | |
IL22RA2 | interleukin 22 receptor, alpha 2 | 0.052 | |
SOCS3 | suppressor of cytokine signaling 3 | 0.051 | |
CD5 | CD5 molecule | 0.050 | |
ANXA2 | annexin A2 | 0.049 | |
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.049 | |
IFNG | interferon, gamma | 0.049 | |
HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.048 | |
GRB10 | growth factor receptor-bound protein 10 | 0.047 | |
SH2D1A | SH2 domain containing 1A | 0.046 | |
IDE | insulin-degrading enzyme | 0.044 | |
C9orf89 | chromosome 9 open reading frame 89 | 0.044 | |
PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.043 | |
APAF1 | apoptotic peptidase activating factor 1 | 0.043 | |
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.043 | |
IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.043 |